Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05743439 · ClinicalTrials.gov registry record · NA

Early Augmentative and Alternative Communication (AAC) Intervention Delivered Via Hybrid Telehealth

A NA study of Intellectual Disability and Speech and Language Disorder, sponsored by Oregon Health and Science University.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT05743439: Recruiting NA study of Intellectual Disability and Speech and Language Disorder, sponsored by Oregon Health and Science University.

NCT05743439 is a NA study of Intellectual Disability and Speech and Language Disorder that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 50 participants, below the 352-participant average among 26 other Intellectual Disability trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05743439, a NA study of Intellectual Disability and Speech and Language Disorder, is actively recruiting participants, sponsored by Oregon Health and Science University.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The goal of this mixed methods study aims to develop and pilot test an augmentative and alternative communication (AAC) intervention for toddlers with intellectual and developmental disabilities (IDD) and their families. The main question it aims to answer is: Will this AAC intervention improve caregivers' use of naturalistic AAC intervention strategies, leading to increases in children's communication? The investigators will employ qualitative methods to conduct interviews to determine caregiver and speech-language pathologist preferences regarding an AAC intervention. Findings from these interviews will inform the adaptation of the AAC intervention procedures, service delivery approach, and strategies to increase caregiver's treatment adherence. Next, the researchers will conduct six multiple baseline designs across behaviors (AAC strategies) to develop the AAC intervention and demonstrate preliminary efficacy when delivered to families in-person. Caregiver-child dyads will receive 24 in-person intervention sessions during which the therapist will provide AAC instruction and coaching on using AAC strategies to caregivers. Last, the investigators will pilot test the AAC intervention using a hybrid telehealth model with nine caregiver-child dyads. Caregiver-child dyads will receive 24 intervention sessions, eight sessions provided to families in-person, and 16 sessions provided to families via telehealth. Our long-term goal is to develop a socially valid and effective intervention to improve language outcomes for toddlers with IDD. The researchers propose developing and pilot testing a hybrid telehealth AAC intervention for toddlers with IDD and their families. Researchers employ an implementation science approach, using systematic qualitative methods to identify caregivers' preferences and single-case experimental design methods to assess the feasibility of the AAC intervention. The central hypothesis is that the intervention will improve caregivers' use of natura

Conditions Studied

Intellectual Disability Speech and Language Disorder

Interventions

  • BEHAVIORAL Early Augmentative and Alternative Communication (AAC) Intervention

Study Locations (1)

Oregon

  • Oregon Health and Science University - Portland

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2022-07-01
Est. Completion 2025-12-31
Phase NA
Oregon Health and Science University

546 total trials

What NCT05743439 shows while recruiting

NCT05743439 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 352-participant average among 26 other Intellectual Disability trials with a reported enrollment target (86% lower).

The record links to 2 conditions, with Intellectual Disability appearing as the primary indexed condition, and to 1 intervention - of which Early Augmentative and Alternative Communication (AAC) Intervention is the first listed.

NCT05743439 reports a single indexed study location in Oregon.

Frequently Asked Questions

What is clinical trial NCT05743439 about?

NCT05743439 is a clinical study titled "Early Augmentative and Alternative Communication (AAC) Intervention Delivered Via Hybrid Telehealth". The goal of this mixed methods study aims to develop and pilot test an augmentative and alternative communication (AAC) intervention for toddlers with intellectual and developmental disabilities (IDD) and their families. The main question it aims to answer is: Will this AAC intervention improve care...

What is the current status of trial NCT05743439?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2022-07-01. Estimated completion is 2025-12-31.

What conditions does trial NCT05743439 study?

This clinical trial studies the following conditions: Intellectual Disability, Speech and Language Disorder.

What interventions are being tested in trial NCT05743439?

The interventions under investigation include: Early Augmentative and Alternative Communication (AAC) Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT05743439?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05743439 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Intellectual Disability

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05743439's enrollment target sits among peer trials

50 20th of 26 higher than 7 of 26 other Intellectual Disability trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Intellectual Disability trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT05743439

Source: ClinicalTrials.gov NCT05743439, the US trial registry maintained by the National Library of Medicine. NCT05743439 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.